THE UNIVERSITY OF CALIFORNIA, DAVIS and Novogene established a genomics sequencing center on the university’s Sacramento campus. Novogene purchased its second Illumina Hi-Seq X Ten system, which can perform whole human genome sequencing for less than $1,000, and will install five sequencers in the new facility, scheduled to open in early May. The center will...
In a unanimous vote, the FDA Oncologic Drugs Advisory Committee advised the agency to accept the metric of “minimal residual disease,” or MRD, as a basis for accelerated approvals of therapies in all settings of multiple myeloma.
